EV/EBITDA
-5.95
-0.10-1.71%
Fri, 07 Feb 2025 00:54:37 GMT
Summary
- As of February 7, 2025, LCTX EV/EBITDA is -5.95, with a fall of -0.10 (-1.71%) during the most recent trading day.
- Over the past year, LCTX EV/EBITDA has increased by +1.40 (+19.05%).
- LCTX EV/EBITDA is now -3031.58% below its all-time high of -0.19.
Performance
LCTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
LCTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.7% | +1.7% | +1.4% |
| 1 m1 month | -30.8% | +30.9% | +24.7% |
| 3 m3 months | +12.8% | -12.7% | -23.7% |
| 6 m6 months | -0.8% | -10.6% | -22.8% |
| ytdytd | -46.9% | +47.1% | +36.8% |
| 1 y1 year | +19.1% | -25.6% | -36.0% |
| 5 y5 years | -11.2% | -31.5% | -45.8% |
LCTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -32.8% | -5.95 | at low | |
| 3 m | 3-month | -3.86 | -54.1% | -7.16 | +16.9% |
| 6 m | 6-month | -3.86 | -54.1% | -7.16 | +16.9% |
| 1 y | 1-year | -3.86 | -54.1% | -10.33 | +42.4% |
| 3 y | 3-year | -2.40 | -147.9% | -11.60 | +48.7% |
| 5 y | 5-year | -2.38 | -150.0% | -18.27 | +67.4% |
| alltime | all time | -0.19 | -3031.6% | -675.37 | +99.1% |
Lineage Cell Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -5.95(+46.9%) |
| 2024 | -4.05(-38.4%) |
| 2023 | -6.58(-25.1%) |
| 2022 | -8.79(+17.4%) |
| 2021 | -7.49(-24.0%) |
| 2020 | -9.86(+173.9%) |
| 2019 | -3.60(+44.6%) |
| 2018 | -2.49(-60.8%) |
| 2017 | -6.36(-2.3%) |
| 2016 | -6.51(+16.0%) |
| 2015 | -5.61(-9.7%) |
| 2014 | -6.21(+8.0%) |
| 2013 | -5.75(-15.4%) |
| 2012 | -6.80(-57.7%) |
| 2011 | -16.08(-57.8%) |
| 2010 | -38.06(-6.9%) |
| Date | Value |
|---|---|
| 2009 | -40.89(+200.9%) |
| 2008 | -13.59(+60.6%) |
| 2007 | -8.46(+151.8%) |
| 2006 | -3.36(+32.8%) |
| 2005 | -2.53(-90.9%) |
| 2004 | -27.74(+17.2%) |
| 2003 | -23.67(+57.6%) |
| 2002 | -15.02(-11.5%) |
| 2001 | -16.98(+0.7%) |
| 2000 | -16.87(+6.4%) |
| 1999 | -15.86(-64.3%) |
| 1998 | -44.42(-9.1%) |
| 1997 | -48.85(+84.0%) |
| 1996 | -26.55(+1170.3%) |
| 1994 | -2.09(-76.7%) |
| 1993 | -8.98(-28.6%) |
| 1992 | -12.58 |
FAQ
- What is Lineage Cell Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Lineage Cell Therapeutics?
- What is LCTX EV/EBITDA year-to-date change?
- What is Lineage Cell Therapeutics EV/EBITDA year-on-year change?
What is Lineage Cell Therapeutics EV/EBITDA?
The current EV/EBITDA of LCTX is -5.95
What is the all time high EV/EBITDA for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high EV/EBITDA is -0.19
What is LCTX EV/EBITDA year-to-date change?
Lineage Cell Therapeutics EV/EBITDA has changed by -1.90 (-46.91%) since the beginning of the year
What is Lineage Cell Therapeutics EV/EBITDA year-on-year change?
Over the past year, LCTX EV/EBITDA has changed by +1.40 (+19.05%)